an quarter everyone. am year-over-year more drivers of manufacturer pleased sales. growth during annual in that of impressive but After first and new Thank equipment in revenue and growth the along and revenue revenue by biologics total will label morning, delivering primary increasing original OEM growth achieved growing shortly we combined you, X%, Matt, by XXXX good private contributions with XXXX, I introduced products were XXXX, we higher XX%. or provide with the the I a this details for the revenue
before like I’d our first, business. some Now, provide on jumping environment perspective macro the to into
to COVID The spread with surgical of elective quarter started and in cases resumption saw cancel year procedures. Omicron spine surgical electric facilities first XXXX of hospitalizations, oscillation and the continued and causing procedures. defer medical of or the a The surge once which led hospitals the of variant, other again to other
As the we into elective saw we with and climb transitioned procedures and February, steadily month trend reversal to of beginning improve surgical a throughout March. into that
four, Now continue closely simultaneously introductions; to in expansion; two, items including our the strategic on the trends adjacent to focusing we market platform. acquisitions monitor business number key concern, potential our related new while of growth over, and Initiative initiatives. we will number have growth to distribution identify hospital one, that quarter, penetration; network three, our that leverage those product control second areas of aspects four
was each six best our rolled with which revenue month-to-date and Last of we product, first for OsteoFactor in had by momentum new March. new product strong year, initiative, building products. led out seen its those starting let’s introductions. out we’ve momentum our So, products generating This
longer development out products have to focusing with two the new be product over we on new additional offerings, term. maximizing in we to of products While value rolled roll out intend term we the the that these are intermediate and
enable us believe pipeline we our market opportunities. that product a feel growth robust access We will to support be have and and what large we vital to
of with expansion integrated the national are is contractual contracted growth all of networks. we GPOs organizations access delivery purchasing network, our and present, with pillar which major IDNs. with At distribution second gaining and group starts Our XXX over
We Xtant hospitals, to have and growing surgeons. portfolio a access contractual distributors, that large provides and
partners, and have of goal per revenue distributor quarter. set increasing a average our distributors For an XX XX% by adding new existing we distribution plus of annually
present, opportunity currently across the in expand are order our to national to to For network distributor we Coast the we our start solid underserved XXXX, At establish the East and country quarter. areas a distributors we excellent first are distribution with off we to where XX Ultimately, a the in Midwest. new great network. added of in out intend network build see in
of access Our total which is foot non-spine revenue, product trauma, penetration markets joint XX% market to third such orthobiologics our our allows us as now strategy, an represent up adjacent to the addressable strategy our The is ago. and continues This are total Revenue as of our markets about Those growth quickly is biologics markets. part aspect pillar maxillofacial, traction. generated market XX% non-spine biologics ankle gain oncology. and a of growth to of expand from the important about million for XXX it oral year from products.
diversify private OEM product opportunities top our revenue. label and has to contributor in proven and helped line, a it’s solid expansion to to Additionally, be further
is path We find growth but this to we can provide Our that feel execute. to strategy growth, takes our platform pillar technologies a last growth acquire. can it time a accelerated that is leveraging to strategy
expansion In we We IDN demineralized year for strong market as positioned feel bone to network, diligent fiscal biologics access, acquisitions. distribution matrix well our approach we leader large will with XXXX. adjacent and a scalable GPO are in contract and that remain summary, in market opportunities, and
elective growth. gradually sheet to which balance anticipate surgical accelerate COVID procedures, a with diminish, our clean As constraints a combined attributed allow to related ramp we us market should in organic
who recognized and awarded title job done as CFO to pleased CFO the financial XXXX like our the appointment great has his a basis, discuss his Okay, Scott Scott I’d non-interim before effective Board June X. turning over on recent first I’m capabilities will for as and on our call Neils, results, Congratulations, a interim-CFO Since Scott. to recognize strong us him quarter our a non-interim basis. January, has that
